- Presentations
- 5
- Markets
- 1
Precedex is a brand of Dexmedetomidine marketed by Hospira, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Dexmedetomidine
- Brand owner
- Hospira
- Registered in
- United States
- Strengths and forms
- 1000 mcg/250 mL injection, 200 mcg/2 mL injection, 200 mcg/50 mL injection, 400 mcg/100 mL injection, 80 mcg/20 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Precedex 1000 mcg/250 mL injectionIntravenous | Hospira | US FDA | Available on request |
| Precedex 200 mcg/2 mL injectionIntravenous | Hospira | US FDA | Available on request |
| Precedex 200 mcg/50 mL injectionIntravenous | Hospira | US FDA | Available on request |
| Precedex 400 mcg/100 mL injectionIntravenous | Hospira | US FDA | Available on request |
| Precedex 80 mcg/20 mL injectionIntravenous | Hospira | US FDA | Available on request |
Equivalent brands
Other brands of Dexmedetomidine.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Precedex
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.